StockData
Lakefront Biotherapeutics NV logo

Lakefront Biotherapeutics NV (LKFT) stock

LKFTNasdaqPharmaceutical PreparationsAlso trades as GLPGF
Financials through fiscal 2025, year ended Dec 31, 2025Score 7/30
$33.31−0.08 (-0.24%)

Close on Nov 20, 2026Market cap $2.20BP/E 6.2Yield –

Lakefront Biotherapeutics gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

For fiscal 2025 it was €1.08B, up 349.6% from the year before.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025€1.08B+349.6%
FY2024Dec 31, 2024€240.79M+5.1%
FY2022Dec 31, 2022€229.17M-1.5%
FY2021Dec 31, 2021€232.76M–

More Lakefront Biotherapeutics figures

See a number that looks wrong?